Skip to main content
63°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about BMY
Recent news which mentions BMY
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast
November 06, 2024
Tickers
BMY
NEWS
NVO
TEVA
Tags
Market News
Guidance
News
From
Benzinga
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
November 04, 2024
Tickers
BMY
MRK
NEWS
SMMT
Tags
Briefs
Biotech
Benzinga
From
Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
November 04, 2024
Tickers
BMY
Tags
Market News
Short Ideas
Trading Ideas
From
Benzinga
Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious
November 01, 2024
Tickers
BMY
NEWS
Tags
Analyst Color
Market News
Expert Ideas
From
Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
October 31, 2024
Tickers
AAPL
AMGN
AMZN
BKNG
Tags
MSFT
Mid Cap
SBUX
From
Benzinga
Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript
October 31, 2024
Tickers
BMY
Tags
BMY
Recent Press Releases
Market News
From
Motley Fool
Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit
October 31, 2024
Tickers
BMY
NEWS
Tags
Top Stories
Stories That Matter
General
From
Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
Tickers
ABBV
AMGN
BIIB
BMY
Tags
INCY
Benzinga
REGN
From
Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
October 30, 2024
Tickers
BMY
GILD
LYEL
NEWS
Tags
SHL
Health Care
Benzinga
From
Benzinga
Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb
October 23, 2024
Tickers
BMY
Tags
BMY
BZI/UOA
Market News
From
Benzinga
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
October 23, 2024
Tickers
BMY
IBRX
MRK
NEWS
Tags
BMY
News
Expert Ideas
From
Benzinga
Why Is Evotec Stock Gaining Today?
October 23, 2024
Tickers
BMY
EVO
NEWS
Tags
Briefs
Biotech
Benzinga
From
Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
October 17, 2024
Tickers
ALMS
BMY
NEWS
TAK
Tags
General
Analyst Ratings
Stories That Matter
From
Benzinga
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
October 16, 2024
Tickers
BMY
JNJ
Tags
JNJ
Market News
Recent Press Releases
From
Motley Fool
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
October 11, 2024
Tickers
BMY
CATX
NEWS
Tags
General
News
BMY
From
Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
October 07, 2024
Tickers
BMY
NEWS
RVPH
Tags
Top Stories
Stories That Matter
Schizophrenia
From
Benzinga
Unveiling 11 Analyst Insights On Bristol-Myers Squibb
October 07, 2024
Tickers
BMY
Tags
BMY
Benzinga
BZI/AAR
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 07, 2024
Tickers
BMY
ELV
HIMS
HUM
Tags
MRK
BMY
Market News
From
Benzinga
S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By 'Strong AI Demand' And 'Margin Expansion'
October 07, 2024
Tickers
AAPL
AI
BMY
GILD
Tags
ETFs
MSFT
AAPL
From
Benzinga
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
October 07, 2024
Tickers
BMY
CRM
PFE
Tags
Pro Project
Biotech
Benzinga
From
Benzinga
Bristol Myers' $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting
October 04, 2024
Tickers
BMY
NEWS
Tags
Health Care
Large Cap
Benzinga
From
Benzinga
2 Passive-Income Stocks to Load Up On in October
October 03, 2024
Tickers
BMY
LMT
Tags
LMT
BMY
Market News
From
Motley Fool
This Is What Whales Are Betting On Bristol-Myers Squibb
October 01, 2024
Tickers
BMY
Tags
BMY
BZI/UOA
Market News
From
Benzinga
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
October 01, 2024
Tickers
BMY
IGMS
NEWS
Tags
Biotech
Briefs
Benzinga
From
Benzinga
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
September 30, 2024
Tickers
BMY
PRME
Tags
BMY
PRME
Recent Press Releases
From
Motley Fool
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
September 30, 2024
Tickers
BMY
NEWS
PRME
Tags
General
Stories That Matter
Equities
From
Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
September 28, 2024
Tickers
BMY
MRNA
PFE
Tags
MRNA
Recent Press Releases
PFE
From
Motley Fool
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
September 27, 2024
Tickers
ABBV
BMY
NEWS
Tags
Top Stories
General
Analyst Ratings
From
Benzinga
14 Stocks Gain Momentum As August Inflation Comes In Below Expectations
September 27, 2024
Tickers
BABA
BHP
BMY
BP
Tags
JD
PYPL
BUD
From
Benzinga
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
September 27, 2024
Tickers
BMY
NEWS
PRTC
Tags
Trading Ideas
Movers
Health Care
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.